Eletriptan

Expert Opinion on Drug Metabolism & Toxicology
G SandriniG Nappi

Abstract

Migraine is a multifactorial chronic central nervous system disorder, characterized by recurrent disabling attacks of moderate-to-severe headache. Symptomatic acute treatment of migraine should provide rapid and effective relief of the headache pain. The introduction of the 5-HT(1B/1D) receptor agonists (triptans) expanded the armamentarium for acute migraine pain treatment. Eletriptan is a second-generation triptan with favorable bioavailability and half-life, a high affinity for 5-HT(1B/1D) receptors and selectivity for cranial arteries. Eletriptan (40 and 80 mg) has been shown to be effective as early as 30 min after administration and well tolerated when compared to placebo. In comparative clinical trials, eletriptan 40 and 80 mg were superior or equivalent to other triptans and have shown a very high safety and tolerability profile across the studies performed. Eletriptan showed the most favorable cost-effectiveness profile when compared with other agents in its class.

References

Jan 1, 1994·European Journal of Clinical Pharmacology·J P OttervangerB H Stricker
Sep 24, 1994·BMJ : British Medical Journal·I Abu-Arefeh, G Russell
Apr 29, 1999·Archives of Internal Medicine·X H HuM L Berger
Aug 3, 1999·Clinical Pharmacology and Therapeutics·D F MuirW S Hillis
Jun 28, 2000·Progress in Neurobiology·P J Goadsby
Jul 7, 2000·Journal of Clinical Pharmacology·D Deleu, Y Hanssens
Mar 3, 2001·PharmacoEconomics·N E Wells, T J Steiner
Apr 23, 2002·Headache·Julio Pascual
May 23, 2002·Journal of Clinical Pharmacology·Ajit K ShahJoel Morganroth
Jul 23, 2002·Cephalalgia : an International Journal of Headache·UNKNOWN Eletriptan Steering Committee in Japan
Oct 23, 2002·Neurology·G SandriniUNKNOWN Eletriptan Steering Committee
Feb 27, 2003·Headache·Ninan T MathewCarolyn R Sikes
Jun 17, 2003·Cephalalgia : an International Journal of Headache·M FärkkiläC Sikes
Jun 20, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·David C EvansRichard Hargreaves
Nov 13, 2003·JAMA : the Journal of the American Medical Association·Walter F StewartRichard Lipton
Nov 18, 2003·Cephalalgia : an International Journal of Headache·G Garcia-RamosJ Hettiarachchi
Dec 23, 2003·Cephalalgia : an International Journal of Headache·C Wöber-BingölP Wessely
Jan 20, 2004·Cephalalgia : an International Journal of Headache·S W PowersA D Hershey
Jan 30, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·Hans-Christoph DienerJayasena Hettiarachchi
Feb 27, 2004·Cephalalgia : an International Journal of Headache·T J SteinerC R Sikes
Apr 28, 2004·Headache·Karin ZebenholzerPeter Wessely
May 19, 2004·Headache·David DodickUNKNOWN Triptan Cardiovascular Safety Expert Panel
Jun 16, 2004·Cephalalgia : an International Journal of Headache·J A GoldsteinN C Jackson
Feb 1, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·J SchoenenJ Hettiarachchi
Apr 19, 2005·Headache·Richard B Lipton, Marcelo E Bigal
May 20, 2005·American Journal of Epidemiology·A C LyngbergR Jensen
Jun 17, 2005·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C VollonoG Di Trapani

❮ Previous
Next ❯

Citations

May 11, 2011·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·H Ilker IpekdalÜmit H Ulaş
Mar 17, 2015·Expert Opinion on Drug Safety·János TajtiLászló Vécsei
Sep 2, 2016·Therapeutic Advances in Neurological Disorders·Matilde CapiPaolo Martelletti

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Neurotherapeutics
G SandriniG Nappi
Expert Review of Neurotherapeutics
Hans-Christoph Diener
The Cochrane Database of Systematic Reviews
D C McCrory, Rebecca N Gray
© 2022 Meta ULC. All rights reserved